FDA Inspection 1218060 — Unique Hospital- Multispecialty & Research Institute
The FDA completed an inspection of Unique Hospital- Multispecialty & Research Institute on August 18, 2023 in Surat. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 18, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Surat (India)
Additional Details
Clinical BA/BE